Candriam SCA’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-393,390
| Closed | -$7.93M | – | 897 |
|
|
2021
Q3 | $7.93M | Sell |
393,390
-24,855
| -6% | -$501K | 0.05% | 316 |
|
|
2021
Q2 | $15.6M | Sell |
418,245
-990,748
| -70% | -$37M | 0.11% | 222 |
|
|
2021
Q1 | $29.8M | Hold |
1,408,993
| – | – | 0.25% | 107 |
|
|
2020
Q4 | $31M | Buy |
1,408,993
+199,787
| +17% | +$4.4M | 0.25% | 107 |
|
|
2020
Q3 | $21.8M | Sell |
1,209,206
-134,063
| -10% | -$2.41M | 0.2% | 125 |
|
|
2020
Q2 | $34.1M | Buy |
1,343,269
+463,769
| +53% | +$11.8M | 0.36% | 65 |
|
|
2020
Q1 | $18.9M | Hold |
879,500
| – | – | 0.21% | 109 |
|
|
2019
Q4 | $19.4M | Buy |
879,500
+160,000
| +22% | +$3.52M | 0.21% | 109 |
|
|
2019
Q3 | $10.3M | Buy |
+719,500
| New | +$10.3M | 0.14% | 177 |
|
|
2019
Q2 | – | Sell |
-447,500
| Closed | -$6.56M | – | 191 |
|
|
2019
Q1 | $6.56M | Hold |
447,500
| – | – | 0.08% | 268 |
|
|
2018
Q4 | $4.78M | Buy |
447,500
+156,000
| +54% | +$1.67M | 0.07% | 290 |
|
|
2018
Q3 | $4.45M | Buy |
+291,500
| New | +$4.45M | 0.06% | 342 |
|
|
2015
Q3 | – | Sell |
-105,000
| Closed | -$1.47M | – | 652 |
|
|
2015
Q2 | $1.47M | Sell |
105,000
-40,000
| -28% | -$558K | 0.03% | 397 |
|
|
2015
Q1 | $3.49M | Buy |
145,000
+35,000
| +32% | +$841K | 0.07% | 313 |
|
|
2014
Q4 | $1.81M | Buy |
+110,000
| New | +$1.81M | 0.04% | 368 |
|